Home > Products > Featured products

Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC66000 N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea Featured N-[(1R)-4-[(Aminoiminomethyl)amino]-1-[[[(1R)-1-(4-hydroxyphenyl)ethyl]amino]carbonyl]butyl]-α-phenylbenzeneacetamide is an anticonvulsant agent with potential for the treatment of generalized tonic-clonic and partial seizures.
DC66001 (E)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide Featured
DC66002 Retinoic acid, methyl ester Featured
DC66003 4-Keto all-trans-Retinoic Acid Methyl Ester Featured
DC66004 NS3861 Featured NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively.
DC66005 2-(indolin-1-yl)-1-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)ethan-1-one Featured
DC66006 Protein kinase inhibitor 6 Featured Protein kinase inhibitor 6 is a protein kinase inhibitor.
DC66007 CDK9-IN-15 Featured CDK9-IN-15 (compound 50) is a potent CDK9 inhibitor.
DC66008 PARP-1-IN-2 Featured PARP-1-IN-2 (compound 11g) is a potent and BBB-penetrated PARP1 inhibitor, with an IC50 of 149 nM. PARP1-IN-2 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. PARP1-IN-2 can induce A549 cells apoptosis.
DC66009 M4 mAChR agonist-1 Featured M4 mAChR agonist-1 (compound 10a) is a potent M4 mAChR agonist with an EC50 >10 μM for human M4.
DC66010 HIF1-IN-3 Featured HIF1-IN-3 (compound F4) is a potent HIF1 inhibitor with an EC50 value of 0.9 μM. HIF1-IN-3 can be used for researching anticancer.
DC66011 PARP1-IN-8 Featured PARP1-IN-8 (compound 11c) is a potent and BBB-penetrated PARP1 inhibitor, with an IC50 of 97 nM. PARP1-IN-8 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549.
DC66012 JAMM protein inhibitor 2 Featured JAMM protein inhibitor 2 (compound 180) is a potent JAMM protease inhibitor with IC50s of 10 μM, 46 μM and 89 μM for thrombin, Rpn11 and MMP2, respectively. JAMM protein inhibitor 2 can be used for researching anticancer
DC66013 (2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)alanine Featured
DC66014 (2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid Featured
DC66015 3-methyl-N-(3-(thiazolo[5,4-b]pyridin-2-yl)phenyl)butanamide Featured
DC66016 Benzo[d]thiazol-2-ylmethyl ((2-fluorophenyl)sulfonyl)-L-alaninate Featured
DC66017 WAY324208 Featured
DC66018 Sirtuin modulator 7 Featured Sirtuin modulator 7 is a sirtuin-modulating compound which may increase the lifespan of a cell, and may be used for research of diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and flushing which would benefit from increased mitochondrial activity.
DC66019 WAY327059 Featured
DC66020 4-(((3-(4-Ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)thio)methyl)benzonitrile Featured
DC66021 WAY-328122 Featured
DC66022 WAY-324485 Featured
DC66023 WAY-642481 Featured
DC66024 2-(4-Chlorophenyl)-N-(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)phenyl)acetamide Featured
DC66025 WAY-324284-A Featured
DC66026 HIV-IN-6 Featured HIV-IN-6 is a HIV-Ⅰ viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck.
DC66027 CFTR corrector 9 Featured CFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. CFTR corrector 9 can be used for researching cystic fibrosis (CF) and other CFTR associated disorders.
DC66028 WAY-313170 Featured inhibition of hedgehog signaling and phosphodiesterase; inhibition of hedgehog signaling and phosphodiesterase.
DC66029 WAY-639234 Featured

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X